Testicular germ cell tumours

The authors of this Clinical Review have alerted us to an error in the first paragraph on “Non-seminoma” under the section “Who needs adjuvant treatment?” (BMJ 2013;347:f5526, doi:10.1136/bmj.f5526). The recurrence rates for retroperitoneal node dissection and adjuvant chemotherapy are listed the wrong way round in the last sentence, which should have read: “A prospective randomised trial compared retroperitoneal node dissection with adjuvant chemotherapy in 382 patients and found recurrence rates within two years of 8% and 1%, respectively.”